New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Yinan Zhang, MD
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
Marisa McGinley, DO
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Ashley Baker, MSN, PMHNP
Morris Goldman, MD
Dara Sanandaji
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
George Bloom, PhD
New Study Shows EBV-Specific T-Cells Contribute to MS Development
J. William Lindsey
A Successful and Safe Stem Cell Therapy for Progressive MS
Charles Turck, PharmD, BCPS, BCCCP
Stefano Pluchino, MD, PhD
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Marc Haut, PhD
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
Hannah Brown, MD
Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?
Logan Schneider, MD
Expert Consensus on How Oxybates Influence Cardiovascular Risk in Narcolepsy Patients
Kevin Trice, MD
Lee Surkin, MD, FACC, FCCP, FASNC, FAASM
Narcolepsy: The Life Essential 8 Connection
Ana C. Krieger, MD
Challenges in Recognizing and Diagnosing Narcolepsy
Professional Recommendations of Clinically Validated Tools Used to Monitor Response to Treatment in Idiopathic Hypersomnia
Matthew Davis, MD
Alcibiades J. Rodriguez, MD, FAASM
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.